| Item Type | Name |
|
Concept
|
Abdomen
|
|
Concept
|
Supervised Machine Learning
|
|
Concept
|
Checkpoint Kinase 1
|
|
Concept
|
Positron Emission Tomography Computed Tomography
|
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
|
Concept
|
Bevacizumab
|
|
Concept
|
Cetuximab
|
|
Concept
|
Adolescent
|
|
Concept
|
Adult
|
|
Concept
|
Animals
|
|
Concept
|
Age Factors
|
|
Concept
|
Aged
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Antibodies
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Antineoplastic Agents, Phytogenic
|
|
Concept
|
Algorithms
|
|
Concept
|
Calcium
|
|
Concept
|
Calcium-Binding Proteins
|
|
Concept
|
Canada
|
|
Concept
|
Action Potentials
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Carcinoma
|
|
Concept
|
Adenocarcinoma, Mucinous
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Blood Platelets
|
|
Concept
|
Blood Vessels
|
|
Concept
|
Bone and Bones
|
|
Concept
|
Brachytherapy
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Catheters, Indwelling
|
|
Concept
|
Benzimidazoles
|
|
Concept
|
Benzodiazepines
|
|
Concept
|
Benzopyrans
|
|
Concept
|
Bridged-Ring Compounds
|
|
Concept
|
Cisplatin
|
|
Concept
|
Cost-Benefit Analysis
|
|
Concept
|
Counseling
|
|
Concept
|
Creatinine
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Etoposide
|
|
Concept
|
Cystathionine gamma-Lyase
|
|
Concept
|
Colposcopy
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Fallopian Tube Neoplasms
|
|
Concept
|
Fallopian Tubes
|
|
Concept
|
Fasting
|
|
Concept
|
Fatigue
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Female
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Drug Evaluation, Preclinical
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Drug Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Electrocardiography
|
|
Concept
|
Electrocoagulation
|
|
Concept
|
Gynecology
|
|
Concept
|
Humans
|
|
Concept
|
Heart Conduction System
|
|
Concept
|
Heart Rate
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Genital Neoplasms, Female
|
|
Concept
|
Life Style
|
|
Concept
|
Long QT Syndrome
|
|
Concept
|
Lymph Node Excision
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Glycolysis
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Laparotomy
|
|
Concept
|
Male
|
|
Concept
|
Injections, Intraperitoneal
|
|
Concept
|
Injections, Intravenous
|
|
Concept
|
Length of Stay
|
|
Concept
|
Neutropenia
|
|
Concept
|
Multienzyme Complexes
|
|
Concept
|
Mutation
|
|
Concept
|
Myelodysplastic Syndromes
|
|
Concept
|
NADH, NADPH Oxidoreductases
|
|
Concept
|
Nausea
|
|
Concept
|
Obesity
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Neoplasms
|
|
Concept
|
Neoplasms, Glandular and Epithelial
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Platinum
|
|
Concept
|
Pneumonia, Viral
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Poly(ADP-ribose) Polymerases
|
|
Concept
|
Middle Aged
|
|
Concept
|
Phenotype
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Population Surveillance
|
|
Concept
|
Postoperative Complications
|
|
Concept
|
Phthalazines
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Piperazines
|
|
Concept
|
Piperidines
|
|
Concept
|
Placebos
|
|
Concept
|
Retroperitoneal Space
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Pelvis
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
ROC Curve
|
|
Concept
|
Peripheral Nervous System Diseases
|
|
Concept
|
Peritoneal Neoplasms
|
|
Concept
|
Laparoscopy
|
|
Concept
|
Thrombocytopenia
|
|
Concept
|
Peritoneum
|
|
Concept
|
Gynecologic Surgical Procedures
|
|
Concept
|
Pyrazines
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Time Factors
|
|
Concept
|
Pyrimidinones
|
|
Concept
|
Pyrroles
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Tablets
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Pyruvate Dehydrogenase Complex
|
|
Concept
|
Quality of Life
|
|
Concept
|
Quinolines
|
|
Concept
|
Radiographic Image Interpretation, Computer-Assisted
|
|
Concept
|
Radiography
|
|
Concept
|
Radiotherapy
|
|
Concept
|
Therapeutic Equivalency
|
|
Concept
|
Biomarkers
|
|
Concept
|
Weight Loss
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Recombinant Fusion Proteins
|
|
Concept
|
Recurrence
|
|
Concept
|
5'-Nucleotidase
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Apoptosis
|
|
Concept
|
Paclitaxel
|
|
Concept
|
Annexin A5
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Salvage Therapy
|
|
Concept
|
Endometrial Neoplasms
|
|
Concept
|
Uterine Neoplasms
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Drug Monitoring
|
|
Concept
|
Vaginal Smears
|
|
Concept
|
Vesicovaginal Fistula
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Laser Coagulation
|
|
Concept
|
Immunoconjugates
|
|
Concept
|
Food-Drug Interactions
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Patient Selection
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Quality-Adjusted Life Years
|
|
Concept
|
Radiotherapy, Adjuvant
|
|
Concept
|
Conization
|
|
Concept
|
Sirolimus
|
|
Concept
|
Neoplasms, Second Primary
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Maximum Tolerated Dose
|
|
Concept
|
Neoadjuvant Therapy
|
|
Concept
|
Germ-Line Mutation
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Health Care Reform
|
|
Concept
|
Carcinoma, Adenosquamous
|
|
Concept
|
Papillomavirus Infections
|
|
Concept
|
Adenocarcinoma, Clear Cell
|
|
Concept
|
Carcinoma, Endometrioid
|
|
Concept
|
Cystadenocarcinoma, Serous
|
|
Concept
|
Cervical Intraepithelial Neoplasia
|
|
Concept
|
Neoplasms, Cystic, Mucinous, and Serous
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Neoplasm, Residual
|
|
Concept
|
Prodrugs
|
|
Concept
|
Prognosis
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Taxoids
|
|
Concept
|
Genes, BRCA2
|
|
Concept
|
BRCA2 Protein
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Cation Transport Proteins
|
|
Concept
|
Mice
|
|
Concept
|
Pandemics
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Cytoreduction Surgical Procedures
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
United States
|
|
Concept
|
Response Evaluation Criteria in Solid Tumors
|
|
Concept
|
Folate Receptor 1
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Topoisomerase II Inhibitors
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Cardiotoxicity
|
|
Concept
|
Epothilones
|
|
Concept
|
Comorbidity
|
|
Concept
|
Chemoradiotherapy
|
|
Concept
|
Placebo Effect
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Incidence
|
|
Concept
|
Prevalence
|
|
Concept
|
Survival Rate
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Blood Loss, Surgical
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Homologous Recombination
|
|
Concept
|
Carboplatin
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Maintenance Chemotherapy
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Karnofsky Performance Status
|
|
Concept
|
Wnt Signaling Pathway
|
|
Concept
|
Age of Onset
|
|
Concept
|
Platinum Compounds
|
|
Concept
|
Postmenopause
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
OX40 Ligand
|
|
Concept
|
Retreatment
|
|
Concept
|
BRCA1 Protein
|
|
Concept
|
Genes, BRCA1
|
|
Concept
|
Lymphatic Vessels
|
|
Concept
|
Angiopoietin-1
|
|
Concept
|
Angiopoietin-2
|
|
Concept
|
Microsatellite Instability
|
|
Concept
|
DNA Mismatch Repair
|
|
Concept
|
Subcutaneous Fat
|
|
Concept
|
Intra-Abdominal Fat
|
|
Concept
|
Abdominal Fat
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Gene Expression Profiling
|
|
Concept
|
Ataxia Telangiectasia Mutated Proteins
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Genomics
|
|
Concept
|
Mitochondrial Membrane Transport Proteins
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Microarray Analysis
|
|
Concept
|
Consensus
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
DNA-Activated Protein Kinase
|
|
Concept
|
Young Adult
|
|
Concept
|
Neoplasm Grading
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Patient Safety
|
|
Concept
|
Administration, Intravenous
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
Aorta, Abdominal
|
|
Concept
|
Arrhythmias, Cardiac
|
|
Concept
|
Ascitic Fluid
|
|
Concept
|
Uterine Cervical Dysplasia
|
|
Concept
|
Uterine Cervical Neoplasms
|
|
Concept
|
Cervix Uteri
|
|
Concept
|
Diagnostic Imaging
|
|
Concept
|
Diarrhea
|
|
Concept
|
Diet
|
|
Concept
|
Dietary Fats
|
|
Concept
|
Dipeptidases
|
|
Concept
|
DNA Damage
|
|
Concept
|
DNA Mutational Analysis
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Forecasting
|
|
Concept
|
Hyperinsulinism
|
|
Concept
|
Hysterectomy
|
|
Concept
|
Image Interpretation, Computer-Assisted
|
|
Concept
|
Image Processing, Computer-Assisted
|
|
Concept
|
Immunoglobulin Fc Fragments
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Immunotherapy
|
|
Concept
|
Indazoles
|
|
Concept
|
Maytansine
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Medical Records
|
|
Concept
|
Oklahoma
|
|
Concept
|
Oligopeptides
|
|
Concept
|
Omentum
|
|
Concept
|
Organoplatinum Compounds
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Ovariectomy
|
|
Concept
|
Oxidative Phosphorylation
|
|
Academic Article
|
Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy.
|
|
Academic Article
|
Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma.
|
|
Academic Article
|
A LEEP cervical conization is rarely indicated for a two-step discrepancy.
|
|
Academic Article
|
Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
|
|
Academic Article
|
Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
|
|
Academic Article
|
Treatment Advances in Locoregionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree That More Is Not Always Better?
|
|
Academic Article
|
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors.
|
|
Academic Article
|
Society of Gynecologic Oncology 2016 Annual Meeting: Highlights and context.
|
|
Academic Article
|
Applying a computer-aided scheme to detect a new radiographic image marker for prediction of chemotherapy outcome.
|
|
Academic Article
|
Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.
|
|
Academic Article
|
Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.
|
|
Academic Article
|
A two-step convolutional neural network based computer-aided detection scheme for automatically segmenting adipose tissue volume depicting on CT images.
|
|
Academic Article
|
MICU1 drives glycolysis and chemoresistance in ovarian cancer.
|
|
Academic Article
|
The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer.
|
|
Academic Article
|
Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
|
|
Academic Article
|
Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
|
|
Academic Article
|
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
|
|
Academic Article
|
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis.
|
|
Academic Article
|
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
|
|
Academic Article
|
Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes.
|
|
Academic Article
|
Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer.
|
|
Academic Article
|
Endometrial Cancer: Is This a New Disease?
|
|
Academic Article
|
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
|
|
Academic Article
|
Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development.
|
|
Academic Article
|
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.
|
|
Academic Article
|
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study.
|
|
Academic Article
|
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
|
|
Academic Article
|
Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States.
|
|
Academic Article
|
Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients.
|
|
Academic Article
|
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.
|
|
Academic Article
|
Cervical dysplasia among women over 35 years of age.
|
|
Academic Article
|
Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.
|
|
Academic Article
|
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study.
|
|
Academic Article
|
Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.
|
|
Academic Article
|
Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
|
|
Academic Article
|
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
|
|
Academic Article
|
Is the NCI MATCH trial a match for gynecologic oncology?
|
|
Academic Article
|
Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients.
|
|
Academic Article
|
Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer.
|
|
Academic Article
|
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer.
|
|
Academic Article
|
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.
|
|
Academic Article
|
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models.
|
|
Academic Article
|
A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer.
|
|
Academic Article
|
Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
|
|
Academic Article
|
Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?
|
|
Academic Article
|
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors.
|
|
Academic Article
|
Patterns and utility of routine surveillance in high grade endometrial cancer.
|
|
Academic Article
|
Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis.
|
|
Academic Article
|
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
|
|
Academic Article
|
Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.
|
|
Academic Article
|
Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer.
|
|
Grant
|
Targeting HPV Consequences in a Cervical Cancer Clinical Trial
|
|
Grant
|
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
|
|
Grant
|
Lead Academic Participating Site for the Development and Conduct of NCTN Trials
|
|
Academic Article
|
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
|
|
Academic Article
|
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database.
|
|
Academic Article
|
Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer.
|
|
Academic Article
|
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.
|
|
Academic Article
|
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial.
|
|
Academic Article
|
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer.
|
|
Academic Article
|
Homologous recombination deficiency testing in first-line ovarian cancer.
|
|
Academic Article
|
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
|
|
Academic Article
|
Recent advances and clinical applications of deep learning in medical image analysis.
|